Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

About this trial

The goal of this observational study is to evaluate the implementation of a structured, digital, nurse-led, remote monitoring care pathway for cardiovascular risk management (CVRM). Participants will receive this care as part of routine clinical practice. In addition to standard follow-up, participants will complete questionnaires on quality of life, medication adherence, system usability, and patient satisfaction.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years

All patients enrolled in the program (high-risk and very high-risk patients)

Disqualifiers

Not able to provide informed consent

No access to smartphone and/or tablet

Inability to use digital tools required for the program

Trial population

All patients enrolled in the digital CVRM program will be invited to participate in this registry.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Number of patients on-target for LDL-c

Proportion of patients achieving guideline-recommended LDL-c targets

Time frame
Baseline and 1 year

Secondary outcomes

1

Mean LDL-c

The mean of LDL-c values in mmol/L, measured at-home

Time frame
Baseline and 1 year follow-up
2

Number of patients achieving blood pressure control

Proportion of patients achieving guideline-recommended blood pressure targets

Time frame
Baseline and 1 year
3

Change in home-measured blood pressure values

Change in blood pressure values measured at home with telemonitoring in mmHg

Time frame
Baseline and 1 year
4

Number of medication changes

Changes in lipid-lowering and antihypertensive medications, defined as change in dose and change in medication type

Time frame
1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.